AI FOMO Is Pushing Family Offices Deeper Into Tech Bets
Ultra-wealthy family offices are feeling the pull of AI investment fear, a new survey suggests, mirroring broader market enthusiasm for the sector.
Even the most insulated corners of private wealth management are not immune to the gravitational pull of artificial intelligence. A new survey highlighted by CNBC suggests that family offices — the bespoke investment firms that manage the fortunes of ultra-high-net-worth families — are increasingly channeling capital into technology and AI-driven opportunities, motivated at least in part by a fear of missing out on what many view as a generational shift in the economy.
Family offices have long prided themselves on a patient, conviction-driven investment philosophy, one that theoretically insulates them from the herd mentality that can buffet retail investors and even institutional funds. The survey findings complicate that self-image. When even sophisticated, long-horizon investors feel compelled to chase a theme, it signals just how dominant AI has become as a narrative force across asset classes and wealth tiers.
Read more Midterm Elections Historically Fuel Strong Stock Market Gains →
The broader implication is worth sitting with. FOMO-driven capital allocation — regardless of the investor's sophistication — carries inherent risk. Family offices allocating to AI out of anxiety rather than deep analytical conviction may find themselves overexposed if the sector's lofty valuations face a correction or if the timeline for AI's commercial payoff proves longer than the current enthusiasm implies.
Still, it would be reductive to frame every family office move toward AI as irrational exuberance. Many of these firms have in-house analytical capabilities that rival institutional managers, and some are making deliberate, research-backed bets on infrastructure, semiconductors, and enterprise software that underpin the AI buildout. The survey, however, raises a legitimate question about how much of this capital is strategic versus reactive — a distinction that will likely determine long-term outcomes.
Continue reading at CNBC.